Turn Therapeutics (TTRX) EBITDA (2024 - 2026)

Turn Therapeutics' quarterly EBITDA came in at -$1.2 million in Q1 2026, down 223.68% year-on-year from $1.0 million in Q1 2025, and up 43.19% quarter-over-quarter from -$2.2 million in Q4 2025.

Turn Therapeutics has reported EBITDA for 3 years, with the latest figure at -$1.2 million in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA fell 223.68% year-over-year to -$1.2 million; the trailing twelve-month figure through Mar 2026 stood at -$5.7 million (changed N/A YoY), and the FY2025 full-year result was -$5.9 million, down 226.0% from the prior year.
  • EBITDA for Q1 2026 stood at -$1.2 million, up from -$2.2 million in the prior quarter.
  • The five-year high for EBITDA was -$328957.0 in Q4 2024, with the low at -$2.2 million in Q4 2025.
  • Average EBITDA over 3 years is -$1.1 million, with a median of -$959567.5 recorded in 2024.
  • Peak annual rise in EBITDA reached 184.34% in 2025, while the deepest fall reached 566.83% in 2025.
  • Tracing TTRX's EBITDA over 3 years: stood at -$328957.0 in 2024, then plunged by 566.83% to -$2.2 million in 2025, then jumped by 43.19% to -$1.2 million in 2026.
  • The last three EBITDA figures came in at -$1.2 million (Q1 2026), -$2.2 million (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.63 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -19.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14.44 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.14 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.82 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 661.60 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 201.19 Mn
10 Turn Therapeutics 188.06 Mn 188.06 Mn - -1.25 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.25 Mn
Dec 31, 2025 -2.19 Mn
Sep 30, 2025 -1.91 Mn
Mar 31, 2025 -384,997.00
Dec 31, 2024 -328,957.00
Sep 30, 2024 -672,992.00